Clinical trial
Cochlear Implant With Dexamethasone Eluting Electrode Array (The CI-DEX Study): Pivotal Study
NCT04750642 is registered in ClinicalTrials.gov with Cochlear as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Cochlear Implant With Dexamethasone Eluting Electrode Array (The CI-DEX Study): Pivotal Study
- Lead sponsor
- Cochlear
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 4, 2021
- Completion date
- February 23, 2024
- Enrollment
- 42 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
bilateral hearing loss, sensorineural hearing loss